[go: up one dir, main page]

PT1000541E - Solucao medica definida isenta de soro para oftalmologia - Google Patents

Solucao medica definida isenta de soro para oftalmologia

Info

Publication number
PT1000541E
PT1000541E PT99308702T PT99308702T PT1000541E PT 1000541 E PT1000541 E PT 1000541E PT 99308702 T PT99308702 T PT 99308702T PT 99308702 T PT99308702 T PT 99308702T PT 1000541 E PT1000541 E PT 1000541E
Authority
PT
Portugal
Prior art keywords
supplements
nutrient
ophthalmology
growth factor
medical solution
Prior art date
Application number
PT99308702T
Other languages
English (en)
Inventor
Debra L Skelnik
Original Assignee
Debra L Skelnik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debra L Skelnik filed Critical Debra L Skelnik
Publication of PT1000541E publication Critical patent/PT1000541E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides or bases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C12N2501/392—Sexual steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT99308702T 1998-11-05 1999-11-02 Solucao medica definida isenta de soro para oftalmologia PT1000541E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/186,580 US6153582A (en) 1998-11-05 1998-11-05 Defined serumfree medical solution for ophthalmology

Publications (1)

Publication Number Publication Date
PT1000541E true PT1000541E (pt) 2004-08-31

Family

ID=22685497

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99308702T PT1000541E (pt) 1998-11-05 1999-11-02 Solucao medica definida isenta de soro para oftalmologia

Country Status (9)

Country Link
US (1) US6153582A (pt)
EP (1) EP1000541B1 (pt)
JP (1) JP2000198701A (pt)
AT (1) ATE257648T1 (pt)
AU (1) AU769082B2 (pt)
CA (1) CA2288540C (pt)
DE (1) DE69914160T2 (pt)
ES (1) ES2217700T3 (pt)
PT (1) PT1000541E (pt)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849612B2 (en) * 1993-01-21 2005-02-01 Isis Pharmaceuticals, Inc. Oligonucleotide modulation of cell adhesion
US6974796B1 (en) 1999-08-17 2005-12-13 Girsh Leonard S Therapeutic compositions for treatment of a damaged tissue
US20070231402A1 (en) * 1994-08-02 2007-10-04 Immunopath Profile, Inc. Therapeutic stem cell composition and stimulant, facilitator, accelerator, and synergizer thereof, growth factor, anti-inflammatory composition and uses thereof
US20090274660A1 (en) * 1999-08-17 2009-11-05 Immunopath Profile, Inc. Pluripotent therapeutic compositions and uses thereof
US7790678B1 (en) * 1999-08-17 2010-09-07 Immunopath Profile, Inc. Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy and anti-cancer activity and methods of use
US20070037777A1 (en) * 2005-08-12 2007-02-15 Immunopath Profile, Inc. Lipid-containing compositions and methods of using them
EP1251867A4 (en) 2000-02-04 2004-12-08 Unigene Lab Inc NASAL CALCITON INFORMATION
US7611830B2 (en) * 2000-04-10 2009-11-03 The United States Of America As Represented By The Department Of Veteran's Affairs Device to lavage a blood vessel
US6569615B1 (en) * 2000-04-10 2003-05-27 The United States Of America As Represented By The Department Of Veteran's Affairs Composition and methods for tissue preservation
US6762053B2 (en) * 2000-06-09 2004-07-13 Vitrolife, Inc. Mammalian gamete and embryo culture media and culture media supplements
AU2002214821B2 (en) * 2000-11-14 2003-08-14 Vital Health Sciences Pty Ltd Complexes of phosphate derivatives
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
GB0028414D0 (en) 2000-11-22 2001-01-03 Univ Leeds Flush preservation solution
DE10133196A1 (de) * 2001-07-07 2003-01-23 Beiersdorf Ag Nicotinsäure enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
US8008345B2 (en) 2001-07-27 2011-08-30 Vital Health Sciences Pty. Ltd. Dermal therapy using phosphate derivatives of electron transfer agents
WO2003022046A1 (en) * 2001-09-10 2003-03-20 University Of Saskatchewan Technologies Inc. Method for cryopreserving mammalian cells and tissues
WO2003045847A2 (de) * 2001-11-16 2003-06-05 Technocon Gmbh Verfahren zur biologischen wasseraufbereitung durch zugabe von makromolekularen kohlenhydraten
CA2473360A1 (en) * 2002-01-25 2003-08-07 Genzyme Corporation Serum-free media for chondrocytes and methods of use thereof
MXPA04007739A (es) * 2002-02-12 2005-07-01 Raven Biotechnologies Inc Celulas epiteliales derivadas de vejiga fetal humana.
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
EP1475434A1 (en) * 2003-05-09 2004-11-10 Oncoscience AG Method for storing tumor cells
FR2856891B1 (fr) * 2003-07-04 2007-09-07 Stem Alpha Milieu de conservation d'organes, de tissus biologiques ou de cellules vivantes
US20050176144A1 (en) * 2004-02-06 2005-08-11 O'daly Jose A. Culture media compositions free of fetal bovine serum
WO2005084678A1 (en) 2004-03-03 2005-09-15 Vital Health Sciences Pty Ltd Alkaloid formulations
BRPI0400935A (pt) * 2004-04-02 2005-11-22 Ernesto Rodriguez Salas Solução para conservação de membranas biológicas e seu uso
JP2005306749A (ja) * 2004-04-19 2005-11-04 Kringle Pharma Inc Ｈｇｆ含有臓器保存液
US8252591B2 (en) 2004-05-07 2012-08-28 Whitehead Institute For Biomedical Research Hormone responsive tissue culture system and uses thereof
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
WO2006092449A2 (en) 2005-03-02 2006-09-08 Metanomics Gmbh Process for the production of fine chemicals
EP1868430B1 (en) * 2005-04-12 2015-07-08 Cleo Cosmetic and Pharmaceutical Co., LLC Composition and method for in vitro preservation of corneal tissues
EP1893159B1 (en) 2005-06-17 2015-09-30 Vital Health Sciences Pty Ltd. A carrier comprising one or more di- and/or monophosphate derivatives of electron transfer agents
CN100362098C (zh) * 2005-09-29 2008-01-16 华东理工大学 适用于多种动物细胞大规模培养的无血清培养基
US20070224588A1 (en) * 2006-03-22 2007-09-27 Biocept, Inc. Trophoblast preservation/pretreatment medium and method
WO2007138119A1 (es) * 2006-05-30 2007-12-06 Instituto Nacional De Investigación Y Tecnología Agraria Y Alimentaria, Inia Procedimiento de preparación de vesículas unilamelares para la criopreservación y cultivo de celulas germinales y embriones
CN100463681C (zh) * 2006-10-24 2009-02-25 北京紫竹药业有限公司 一种治疗干眼症的人工泪液
EP2124539A2 (en) * 2007-02-17 2009-12-02 President and Fellows of Harvard College Compositions and method for tissue preservation
US20110244502A1 (en) 2007-08-10 2011-10-06 Whitehead Institute For Biomedical Research Hormone responsive tissue culture system and uses thereof
AU2009215883A1 (en) 2008-02-15 2009-08-27 President And Fellows Of Harvard College Blood substitute solution
JP5663841B2 (ja) * 2009-02-23 2015-02-04 富士レビオ株式会社 骨細胞への分化誘導培地及び方法
CN101524063B (zh) * 2009-03-23 2012-06-13 姚晓明 角膜中期保存液
SI2451299T1 (sl) 2009-07-10 2016-10-28 Iii Linzy O. Scott Metode in sestave za zdravljenje s ščitnico- povezanih zdravstvenih stanj z reduciranimi folati
FR2948286B1 (fr) * 2009-07-27 2011-08-26 Jean-Noel Thorel Composition injectable associant un agent de comblement et un milieu de croissance des fibroblastes
JP5681472B2 (ja) * 2009-12-28 2015-03-11 ロート製薬株式会社 眼科用組成物
EP2531047B1 (en) 2010-02-05 2024-11-13 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
US9943075B2 (en) * 2010-02-17 2018-04-17 Hememics Biotechnologies, Inc. Preservation solutions for biologics and methods related thereto
JP5806287B2 (ja) 2010-03-30 2015-11-10 フォスファジェニクス リミティド 経皮送達パッチ
US9845457B2 (en) * 2010-04-30 2017-12-19 Cedars-Sinai Medical Center Maintenance of genomic stability in cultured stem cells
EP2685992A4 (en) 2011-03-15 2014-09-10 Phosphagenics Ltd AMINOCHINOLINE AS A KINASEHEMMER
WO2013006969A1 (en) 2011-07-12 2013-01-17 Foodchek Systems, Inc. Culture medium, method for culturing salmonella and e. coli and method for detecting salmonella and e. coli
US9828603B2 (en) 2012-08-13 2017-11-28 Cedars Sinai Medical Center Exosomes and micro-ribonucleic acids for tissue regeneration
CA3153463A1 (en) 2012-10-29 2014-05-08 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders
US20150342175A1 (en) * 2012-12-31 2015-12-03 Somahlution, Llc Organ and tissue preservation formulations with increased stability and shelf life
CN103190392B (zh) * 2013-03-28 2015-07-29 北京大学第三医院 一种角膜中期保存液及其制备方法
US10350232B1 (en) 2013-11-04 2019-07-16 Peter D. Jaillet Medicinal drops
EP3027016B1 (en) 2013-11-22 2019-06-12 Somahlution, LLC Solutons for increasing the stability and shelf life of an organ tissue preservation solution
CA2962444C (en) 2014-10-03 2023-09-05 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
US20160175442A1 (en) * 2014-12-02 2016-06-23 Avedro, Inc. Systems, Methods, and Compositions For Cross-Linking Treatments of an Eye
WO2016129654A1 (ja) * 2015-02-12 2016-08-18 国立大学法人 東京大学 角膜内皮前駆細胞の調製方法
ITUB20150108A1 (it) * 2015-03-04 2016-09-04 Alchilife S R L Molecola antimicotica sintetica e metodo per sintetizzare una molecola antimicotica
WO2016159773A1 (en) 2015-04-03 2016-10-06 Tx Innovations B.V. Organ preservation composition
FR3035407B1 (fr) 2015-04-23 2022-06-17 Francais Du Sang Ets Procede de conservation de cellules, tissus ou organes en hypothermie
FR3040860B1 (fr) * 2015-09-10 2020-05-15 Universite de Bordeaux Milieu de conservation injectable pour la conservation de cellules du sang placentaire, de la moelle osseuse et du sang peripherique
CN108601732A (zh) 2015-12-09 2018-09-28 磷肌酸有限公司 药物制剂
EP3402543B1 (en) 2016-01-11 2021-09-08 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
WO2017210652A1 (en) 2016-06-03 2017-12-07 Cedars-Sinai Medical Center Cdc-derived exosomes for treatment of ventricular tachyarrythmias
US10426796B2 (en) 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US11541078B2 (en) 2016-09-20 2023-01-03 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
KR102647670B1 (ko) 2016-12-21 2024-03-15 아베초 바이오테크놀로지 리미티드 방법
US10265312B1 (en) * 2018-02-01 2019-04-23 Jason Ahee Antibiotic solution and method of injection to prevent ophthalmic infections
WO2018195210A1 (en) 2017-04-19 2018-10-25 Cedars-Sinai Medical Center Methods and compositions for treating skeletal muscular dystrophy
WO2019126068A1 (en) 2017-12-20 2019-06-27 Cedars-Sinai Medical Center Engineered extracellular vesicles for enhanced tissue delivery
US12146137B2 (en) 2018-02-05 2024-11-19 Cedars-Sinai Medical Center Methods for therapeutic use of exosomes and Y-RNAS
CN108841780B (zh) * 2018-06-29 2019-03-12 陕西诺威利华生物科技有限公司 适合大规模生产pedv疫苗的无血清培养基
CN109801994B (zh) * 2019-01-09 2020-11-24 成都中建材光电材料有限公司 一种提升碲化镉电池性能的方法
CA3132533A1 (en) * 2019-03-04 2020-09-10 University Of Iowa Research Foundation Composition comprising an anti-oxidant to preserve corneal tissue
CN110278940A (zh) * 2019-07-11 2019-09-27 河南省农业科学院畜牧兽医研究所 一种猪精子保存剂及其制备方法和应用
WO2021108806A1 (en) * 2019-11-29 2021-06-03 Rutgers, The State University Of New Jersey Compositions, kits and methods for storage of blood products and methods of use thereof
US11904006B2 (en) 2019-12-11 2024-02-20 University Of Iowa Research Foundation Poly(diaminosulfide) particle-based vaccine
CN112602703B (zh) * 2020-12-17 2022-05-27 中山大学附属第三医院 一种细胞、组织或器官冷保存液的制备方法与应用
CN113508807B (zh) * 2021-08-05 2022-03-04 信阳农林学院 一种卵巢常温保存液及其保存方法
CN114190366B (zh) * 2021-12-29 2023-04-07 松山湖材料实验室 冻存液及其制备方法与在人正常肝细胞的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1263606A (en) * 1985-05-29 1989-12-05 Jeffrey P. Gilbard Non-toxic opthalmic preparations
CA2041828A1 (en) * 1990-03-05 1992-11-04 Richard L. Lindstrom Viscoelastic solution
EP0516901A1 (en) * 1991-06-06 1992-12-09 Richard L. Lindstrom Method and apparatus of a serumfree medical solution

Also Published As

Publication number Publication date
AU769082B2 (en) 2004-01-15
CA2288540A1 (en) 2000-05-05
ES2217700T3 (es) 2004-11-01
DE69914160D1 (de) 2004-02-19
EP1000541A1 (en) 2000-05-17
AU5710899A (en) 2000-05-11
DE69914160T2 (de) 2004-09-02
US6153582A (en) 2000-11-28
CA2288540C (en) 2011-07-05
EP1000541B1 (en) 2004-01-14
ATE257648T1 (de) 2004-01-15
JP2000198701A (ja) 2000-07-18

Similar Documents

Publication Publication Date Title
PT1000541E (pt) Solucao medica definida isenta de soro para oftalmologia
GR3018693T3 (en) Define serum-free medical solution and use thereof.
Rubinsky et al. The cryoprotective effect of antifreeze glycopeptides from antarctic fishes
US4696917A (en) Irrigation solution
Ross et al. Enzymes of the γ-glutamyl cycle in the ciliary body and lens
CA2164321A1 (en) Plasma-like solution
WO2007103194A2 (en) Aqueous moisturizers and lubricants and uses thereof
IL190542A0 (en) Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
SE9700827D0 (sv) Ophthalmic composition
Tardif et al. Identification of capacitation‐associated phosphoproteins in porcine sperm electroporated with ATP‐γ‐32P
US5221537A (en) Tissue irrigating solutions
ES2162331T3 (es) Utilizacion del factor de crecimiento del tejido nervioso para conservacion, cultivo o tratamiento de la cornea.
AU745028B2 (en) Secondary cataract inhibitor
Karlan et al. Potentiation of infections by biomaterials: a comparison of three materials
CN112752505A (zh) 用于细胞和/或组织的运输和/或冷冻保存的组合物
US6586247B1 (en) Medium for cultivating animal embryo
WO2009086073A1 (en) Stabilized glycerophosphate-containing surgical irrigating solution
Lindstrom et al. Corneal preservation at 4 degrees C with chondroitin sulfate containing medium
US5380537A (en) Single irrigating solution used in ocular therapy for the endothelium protection and cornea preservation
CA2044494A1 (en) Methods and apparatus of a defined serumfree medical solution
JPH1025201A (ja) 歯牙保存液
Thoene et al. Cystine depletion of cystinotic cells by aminothiols
Winkler Comparison of intraocular solutions on glycolysis and levels of ATP and glutathione in the retina
Desai et al. First report of evaluation of KM media: A new corneal preservation medium
Hull et al. Effect of urokinase on corneal endothelium